Resumen
The Biomedical Catalyst is a UK government funding programme jointly administered by Innovate UK and the Medical Research Council (MRC) since 2012, supporting life sciences research and development. The initiative provides non-dilutive funding to both academic and commercial organizations to accelerate the development and delivery of innovative healthcare products and services while driving growth in the UK's life sciences sector.
Acerca de
The Biomedical Catalyst (BMC) is a joint programme run by Innovate UK and the Medical Research Council (MRC) and was launched in 2012. It was part of a wider package of measures to support the life sciences sector under the Government’s Industrial Strategy with the aims of:
Delivering growth to the UK life sciences sector;
Delivering innovative life sciences products and services more quickly and more effectively into healthcare; and,
Provide support to academic and commercially led R&D in a seamless, effective and efficient manner.
Delivering growth to the UK life sciences sector;
Delivering innovative life sciences products and services more quickly and more effectively into healthcare; and,
Provide support to academic and commercially led R&D in a seamless, effective and efficient manner.
Detalles Clave
Tipo
Grant Program
Ubicación
United Kingdom
Inversión
$4,540,000
Tipo de Financiamiento
Grant
Etapa
Government
Contacto
www.ukspa.org.uk¿Ves información incorrecta o desactualizada?
